Pfizer Inc. (PFE)
29.58
+0.14
(+0.48%)
USD |
NYSE |
Oct 16, 16:00
29.59
+0.01
(+0.03%)
After-Hours: 20:00
Pfizer Market Cap : 168.58B for Oct. 16, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 16, 2026 | 168.58B |
| October 15, 2026 | 167.78B |
| October 14, 2026 | 166.47B |
| October 13, 2026 | 161.68B |
| October 12, 2026 | 161.85B |
| October 09, 2026 | 161.17B |
| October 08, 2026 | 158.55B |
| October 07, 2026 | 159.57B |
| October 06, 2026 | 156.72B |
| October 05, 2026 | 156.21B |
| October 02, 2026 | 158.43B |
| October 01, 2026 | 160.26B |
| September 30, 2026 | 162.54B |
| September 29, 2026 | 163.68B |
| September 28, 2026 | 163.68B |
| September 25, 2026 | 163.39B |
| September 24, 2026 | 161.91B |
| September 23, 2026 | 160.60B |
| September 22, 2026 | 159.17B |
| September 21, 2026 | 158.09B |
| September 18, 2026 | 157.63B |
| September 17, 2026 | 157.52B |
| September 16, 2026 | 156.49B |
| September 15, 2026 | 157.01B |
| September 14, 2026 | 157.98B |
| Date | Value |
|---|---|
| September 11, 2026 | 157.98B |
| September 10, 2026 | 157.58B |
| September 09, 2026 | 158.32B |
| September 08, 2026 | 158.38B |
| September 04, 2026 | 162.14B |
| September 03, 2026 | 164.19B |
| September 02, 2026 | 165.38B |
| September 01, 2026 | 162.71B |
| August 31, 2026 | 162.19B |
| August 28, 2026 | 159.34B |
| August 27, 2026 | 159.69B |
| August 26, 2026 | 161.28B |
| August 25, 2026 | 162.82B |
| August 24, 2026 | 159.40B |
| August 21, 2026 | 159.97B |
| August 20, 2026 | 158.38B |
| August 19, 2026 | 160.94B |
| August 18, 2026 | 155.30B |
| August 17, 2026 | 153.13B |
| August 14, 2026 | 152.68B |
| August 13, 2026 | 152.73B |
| August 12, 2026 | 149.94B |
| August 11, 2026 | 151.71B |
| August 10, 2026 | 154.16B |
| August 07, 2026 | 152.51B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Johnson & Johnson | 615.45B |
| Eli Lilly & Co. | 1.183T |
| Merck & Co., Inc. | 360.30B |
| Bristol Myers Squibb Co. | 122.07B |
| Viatris, Inc. | 21.55B |
Market Cap Related Metrics
| PE Ratio | 39.17 |
| PS Ratio | 2.650 |
| Price to Book Value | 1.979 |
| Price to Free Cash Flow | 15.37 |
| Price | 29.58 |
| Earnings Yield | 2.55% |
| Operating PE Ratio | 9.974 |
| Normalized PE Ratio | 12.21 |